Skip to main navigation Skip to search Skip to main content

The effects of clozapine and risperidone on spatial working memory in schizophrenia

  • Susan R. McGurk
  • , Cameron Carter
  • , Robert Goldman
  • , Michael F. Green
  • , Stephen R. Marder
  • , Haiyi Xie
  • , Nina R. Schooler
  • , John M. Kane
  • Icahn School of Medicine at Mount Sinai

Research output: Contribution to journalArticlepeer-review

59 Scopus citations

Abstract

Objective: The purpose of this investigation was to evaluate the effects of clozapine and risperidone on spatial working memory in patients with schizophrenia. Method: Spatial working memory performance was evaluated at baseline and after 17 and 29 weeks in 97 patients with schizophrenia participating in a multisite trial. Results: Compared with baseline performance while receiving conventional antipsychotic medication, risperidone improved, and clozapine worsened, spatial working memory performance. Conclusions: The differential effects of these medications on spatial working memory may be due to the anticholinergic effects of clozapine and prefrontal dopamine-enhancing effects of risperidone.

Original languageEnglish
Pages (from-to)1013-1016
Number of pages4
JournalAmerican Journal of Psychiatry
Volume162
Issue number5
DOIs
StatePublished - May 2005

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Fingerprint

Dive into the research topics of 'The effects of clozapine and risperidone on spatial working memory in schizophrenia'. Together they form a unique fingerprint.

Cite this